Skip to content

Predict vaginal microbiome profile from metabolites

Predicting microbiome profile and other health related markers from metabolites - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/102085
Enrollment
100
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E638- Other specified nutritional deficiencies

Interventions

Intervention1: Nil: Nil Control Intervention1: NIL: NIL

Sponsors

MicrobioTx Health Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: For Infertility group - Married female patients of reproductive age group having an active married life (regular unprotected intercourse, minimum of 12 months) and with a complaint of being unable to conceive for 1 year. For the control group - females with a history of at least 1 spontaneous conception and no current history of infertility

Exclusion criteria

Exclusion criteria: Participants with a history of alcohol consumption exceeding 20 grams per day Participants taking immunosuppressants, tamoxifen, amiodarone and/or perhexiline; Participants who have taken antibiotics in the last 3 weeks Current use of vaginal creams or pessary Inability to conceive due to male infertility Active genital or gastrointestinal infection Any active illness, psychological and/or pathological condition or chronic disease that would interfere with study participation in the opinion of the Investigator

Design outcomes

Primary

MeasureTime frame
Accuracy of Vaginal Microbiome Test Accuracy is defined as : (True Positive + True Negative)/(True Positive + True Negative + False Positive + False negative) Where True Positive: Microbe present in NGS and predicted by VMT within a 95% Confidence Interval (CI) of the NGS abundance value True Negative: Microbe absent in NGS and predicted by VMT within 95% CI of NGS abundance value (i.e., 0) False Positive: Microbe absent in NGS but predicted by VMT outside 95% CI of NGS abundance value False Negative: Microbe present in NGS but predicted by VMT within 95% CI of abundance value of 0Timepoint: The single time point at which the data will be analysed will be 52 weeks from the start of the study.

Secondary

MeasureTime frame
Design probiotic formulation to improve oral microbial healthTimepoint: The single time point at which the data will be analysed will be 1.5 year from the start of the study.

Countries

India

Contacts

Public ContactDr Palok Aich

MicrobioTx Health Private Limited

hello@microbiotx.com09019343030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026